Tous Actualités
Suivre
Abonner Siemens Healthcare

Siemens Healthcare

Siemens Healthcare Announces Exclusive Partnership With Prowess Inc.

Concord, California (ots/PRNewswire)

- Plans to Integrate Treatment Planning System with Oncology
Solutions  Technology
Siemens Healthcare (www.usa.siemens.com/healthcare) announces an
exclusive partnership with Prowess Inc. to develop advanced radiation
oncology treatment planning software for integration into Siemens'
linear accelerators. The combination of Prowess' unique treatment
planning system with Siemens' leading oncology solutions technology
will help provide users with one of the most effective and reliable
radiation therapy treatment solutions available in the market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )
This agreement authorizes Siemens Healthcare to share the basic
intellectual property of Prowess' patented Direct Aperture
Optimization (DAO) planning software, allowing Siemens to incorporate
Prowess' software into the treatment planning tools for its linear
accelerators. This, in turn, will help users to dramatically reduce
the number of segments, monitor units, and overall treatment times.
"This partnership with Prowess will provide us the ability to
deliver a solution that helps clinical teams treat patients more
efficiently by reducing treatment times, dosage, and exposure of
healthy tissues," said Holger Schmidt, Chief Executive Officer,
Siemens Healthcare, Oncology Care Systems. "The open system
architecture will enable Siemens to offer users one of the broadest
selections of treatment planning tools on the market."
"Working closely with Siemens, we are developing a joint solution
that combines Siemens' innovative oncology therapy solutions with our
market-leading treatment planning system," said John Nguyen, CEO of
Prowess. "We look forward to realizing the full potential of this
partnership and continuing to drive innovation in the oncology
field."
The Prowess DAO-based Plan-to-Patient tool(i) for Adaptive
Radiation Therapy (ART) has been clinically evaluated and is planned
to be available in the spring of 2008. The tool works with Siemens'
unique CTVision(TM) System, a SOMATOM(R) CT Sliding Gantry on rails
combined with an ARTISTE(TM) or ONCOR(TM) Linear Accelerator. DAO
enables users to make on-line plan corrections based on actual
pre-treatment CT scans taken in the treatment room, while the patient
is on the linear accelerator's treatment table.
Siemens is also working on the development of a highly-efficient
single arc radiation treatment called Cone Beam Therapy (CBT)(i). The
combination of CBT with DAO-based planning software will help improve
tumor control for many disease sites, while sparing as much healthy
tissue as possible.
About Siemens Healthcare
Siemens Healthcare is one of the world's largest suppliers to the
healthcare industry. The company is a renowned medical solutions
provider with core competence and innovative strength in diagnostic
and therapeutic technologies as well as in knowledge engineering,
including information technology and system integration. With its
laboratory diagnostics acquisitions, Siemens Healthcare will be the
first fully integrated diagnostics company, bringing together imaging
and lab diagnostics, therapy, and healthcare information technology
solutions, supplemented by consulting and support services. Siemens
Healthcare delivers solutions across the entire continuum of care --
from prevention and early detection, to diagnosis, therapy and care.
The company employs more than 49,000 people worldwide and operates in
130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare
reported sales of euro 9.85 billion (on a pro forma basis including
Dade Behring roughly euro 11 billion), orders of euro 10.27 billion,
and group profit of euro 1.32 billion. Further information can be
found by visiting http://www.siemens.com/healthcare.
About Prowess Inc.
Prowess Inc. is an international radiation cancer treatment
planning software developer based in Chico, California. Under the
direction and leadership of Mr. Nguyen, Prowess has continued to be a
pioneer in Windows-based treatment planning systems for brachytherapy
and external beam therapy. Prowess' systems are noted for their
advanced technology with an efficient and intuitive interface.
Prowess is a registered trademark of Prowess Inc. All other
company and product names may be trademarks or registered trademarks
of their respective companies. Further information can be found by
visiting http://www.prowess.com.
    (i) The Plan to Patient tool and Cone Beam Therapy are works-in-progress,
        require FDA 510(k) pre-market clearance and are presently not
        available for commercial distribution.
    Web site: http://www.siemens.com/healthcare
              http://www.prowess.com

Contact:

Tom Schaffner, +1-610-448-1477, thomas.schaffner@siemens.com; Photo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO